QA: Amicus Therapeutics INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2012_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 66,648,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,438,000
3 remainder_Assets 709,000
4 LiabilitiesCurrent 19,256,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,880,000
9 ResearchAndDevelopmentExpense 50,856,000
10 remainder_Expenses -4,660,000
11 remainder_Revenues 21,434,000
12 remainder_NetIncome 230,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 69,795,000
1 Liabilities 19,256,000
2 Expenses 66,076,000
3 Revenues 21,434,000
4 StockholdersEquity 50,539,000
5 NetIncome -44,412,000
6 ComprehensiveNetIncome -44,412,000
7 BaseVar 88,395,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.48
9 EconomicCapitalRatio 2.66

Edgar->Model Mapping

Feature Distribution